Connect with us
🔹 Oil price jumps to $115 after reports of 'extended' Iran blockade 🔹 Police raid religious group in modern slavery inquiry 🔹 Woman guilty of murdering sister in Camden home 🔹 Irish government announces further fuel supports after protests 🔹 Inquiry into 'sickening' waste dump at protected site

Uncategorized

REMSleep Receives Medicare PDAC Coding Approval for Complete DeltaWave Product Portfolio

Published

on

REMSleep Holdings, Inc. (OTCQB: RMSL), a developer of the FDA-cleared DeltaWave™ nasal pillow system, today announced that it has received Healthcare Common Procedure Coding System (HCPCS) approvals from the Pricing, Data Analysis, and Coding (PDAC) contractor for the entire DeltaWave product portfolio. This approval allows durable medical equipment (DME) providers to bill Medicare and private insurance payors for all configurations of the DeltaWave system.

The PDAC coding approvals represent the final regulatory requirement needed for REMSleep’s full commercial launch. With expanded FDA 510(k) clearance granted on January 7 and full reimbursement coding now in place, REMSleep is poised to begin nationwide distribution across home care, institutional, and sleep laboratory settings.

“This marks a critical milestone for our DME partners who now have everything they need the expanded FDA clearance, HCPCS codes for all configurations, and a fully stocked inventory,” said Thomas Wood, CEO and founder of REMSleep. “We are excited to proceed with the full commercial launch of DeltaWave, offering a solution that meets the diverse needs of the sleep therapy market.”

Expanded Product Portfolio Reflects Customer Feedback

The DeltaWave product portfolio expansion was informed by feedback from early adoption partners during REMSleep’s Q4 2025 soft launch. DME providers and sleep laboratories identified specific component combinations and sizing variations that were required to better serve their patient populations.

“Some providers prefer complete systems, while others need separate components tailored to their patient demographics,” explained Jeff Marshall, REMSleep’s operations manager. “Sleep labs also requested pillow-only options for diagnostic titration. This feedback was integral in shaping the final product offering.”

Timeline of Regulatory and Commercial Milestones

Since December 2025, REMSleep has achieved a series of key operational milestones:

  • January 7, 2026: FDA 510(k) clearance expanded to include a wider patient demographic and multiple care environments.
  • December 9, 2025: Supplemental 510(k) application submitted to the FDA.
  • December 16, 2025: Infrastructure buildout, including ERP systems and sales force training, announced.
  • December 23, 2025: Early market validation received, with zero product returns and repeat orders.
  • January 21, 2026: Complete PDAC coding approval for all DeltaWave configurations.

 

“We have transitioned from a soft launch with a limited FDA clearance to being fully prepared for national distribution,” Wood said. “This is a significant leap toward providing a complete solution for our customers.”

Commercial Strategy and Market Entry

With regulatory and reimbursement barriers now cleared, REMSleep is activating its three-channel strategy:

  • DME/HME Rescue Mask Positioning: Sales representatives are reaching out to DME providers, targeting the 20-30% of CPAP patients who fail their initial mask. All billing codes are in place to support this market.
  • Sleep Laboratory Partnerships: DeltaWave will be available for use in diagnostic titration, ensuring that patients can access the same mask through insurance after their lab visit.
  • Institutional Sales: REMSleep will begin supplying DeltaWave to hospital respiratory departments and long-term care facilities for use in BiPAP and ventilation support.

 

“We are now fully equipped to execute our strategy across multiple channels,” said Marshall. “With all regulatory approvals in place, we are ready to move forward with our full-scale launch.”

About REMSleep Holdings, Inc.

REMSleep Holdings, Inc. (OTCQB: RMSL) is a medical device company focused on enhancing outcomes for patients requiring positive airway pressure therapy. The company’s DeltaWave™ nasal pillow system is FDA-cleared for use with CPAP, BiPAP, and other non-invasive positive pressure devices in both home and institutional settings. All DeltaWave products have received PDAC coding approval for Medicare and private insurance reimbursement.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including but not limited to: market acceptance of the DeltaWave system, DME provider adoption rates, the company’s ability to achieve targeted sales volumes, reimbursement practices by private payors, and general market conditions. REMSleep undertakes no obligation to update these forward-looking statements.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

ChimpX AI Raises $2.8 Million Seed Round to Make DeFi Simple for Everyone

Published

on

Funding will accelerate development of Mojo AI – the agent that turns plain-English intent into on-chain DeFi execution

ChimpX today announced the close of a $2.8 million seed round at a $24 million fully diluted valuation. The round was led by Waterdrip Capital and MetaLabs Ventures, with participation from Mindfulness Capital, NEURALHASH Capital, Marshland Capital, Maven Capital, Attention Venture, and BRINC.

mojo1 ChimpX AI Raises $2.8 Million Seed Round to Make DeFi Simple for Everyone

Proceeds will be used to expand ChimpX’s core infrastructure, enhance the Mojo AI execution agent, and support the $CHIMP token launch.

The Problem ChimpX Is Solving

DeFi remains inaccessible to most people. Not because the technology is unproven – yields are real, ownership is real, and the underlying protocols are world class. The problem is UX. Gas tokens on every chain. Nine different apps for one strategy. Forty-five minutes for a $500 trade. The average person tries DeFi once and never comes back.

mojo2 ChimpX AI Raises $2.8 Million Seed Round to Make DeFi Simple for Everyone

ChimpX was built to close that gap.

How It Works

At the core of ChimpX is Mojo, an AI execution agent that lets users interact with DeFi through natural language. A user types “optimise yield on my USDC” and Mojo handles the rest – interpreting intent, selecting protocols, constructing the strategy, routing the transaction, and executing on-chain. Automatically. Without requiring the user to manage gas tokens, navigate separate interfaces, or understand the underlying protocols.

mojo3 ChimpX AI Raises $2.8 Million Seed Round to Make DeFi Simple for Everyone

A key component is ChimpX’s gas abstraction layer, which allows users to pay fees in stablecoins such as USDC or USDT while the system handles native token requirements in the background.

Traction

ChimpX has demonstrated strong organic adoption since launch, with organic user growth

  • 56,000+ unique wallets connected
  • $3.9M+ in transaction volume
  • 100,000+ AI prompts executed
  • 15,000+ active users

mojo4 ChimpX AI Raises $2.8 Million Seed Round to Make DeFi Simple for Everyone

The platform supports trading, lending, borrowing, bridging, and derivatives – unified under a single AI-driven interface across BNB Chain, with a Solana launch planned for Q2 2026.

What Mojo AI Does Next

The next phase of development expands the intelligence and autonomy of the Mojo AI agent with:

  • Natural-language strategy composition – complex intent converted automatically into executable multi-step strategies
  • Advanced order automation – limit orders, stop-loss, take-profit, and DCA scheduling
  • Risk-aware execution – dynamic position sizing based on real-time market signals
  • On-chain intelligence – whale tracking, behavioural signals, and sentiment inputs
  • Agent-to-agent transactions – autonomous economic interactions between AI agents

 

To ensure trust and safety, ChimpX integrates verifiable on-chain agent identity, full auditability of agent actions, user-configurable controls, and a guardrail system preventing prompt injection.

Investor Perspective

“We see AI agents becoming the primary interface for financial systems. ChimpX is early in building that layer for DeFi — where users express intent, and intelligent agents execute autonomously. This is not just a UX improvement, it’s a paradigm shift.”
Partner, MetaLabs Ventures

Founder Statement

“Most people who tried DeFi once never came back. Not because DeFi is bad – the protocols are genuinely extraordinary. The experience of using them is just broken. We built ChimpX because we believe that problem is completely solvable. Mojo is the proof.”
Akshay Nassa, CEO & Co-Founder, ChimpX

$CHIMP Token

The $CHIMP token serves as the coordination layer within the ChimpX ecosystem, enabling fee participation, staking, and governance. The token is designed to support sustainable ecosystem growth.

mojo5 ChimpX AI Raises $2.8 Million Seed Round to Make DeFi Simple for Everyone

About ChimpX

ChimpX is building Mojo AI – making DeFi simple for everyone. Users tell Mojo what they want in plain English. Mojo handles everything else. No gas tokens. No fragmented apps. Just done.

chimpx.ai | app.chimpx.ai | x.com/chimpxAI | t.me/chimpxofficial | discord.gg/8Fq4nt3Xwh

Media Contact

Akshay Nassa, CEO

[email protected]

chimpx.ai

Continue Reading

Uncategorized

Bloomberg Profile: Brian Ferdinand — May 2026

Published

on

A Bloomberg-style profile feature has spotlighted Brian Ferdinand for his work in systematic trading and multi-asset portfolio management at EverForward Trading.

WhatsApp Image 2026 04 29 at 10.54.43 AM Bloomberg Profile: Brian Ferdinand — May 2026

The feature highlights Ferdinand’s structured approach to building risk-managed strategies designed to navigate volatility and shifting macroeconomic conditions. His work is centered on consistency, execution discipline, and the application of quantitative frameworks.

Brian Ferdinand is an active member of the Forbes Finance Council, portfolio manager, and trader at EverForward Trading. He focuses on structured, risk-managed multi-asset strategies designed to deliver consistent performance across shifting macroeconomic and volatility regimes, with an emphasis on capital efficiency, drawdown control, and systematic execution.
Ferdinand has earned multiple industry awards recognizing his performance and innovation, including the Global Systematic Trading Performance Award (GSTPA) for sustained, model-driven results and strong risk-adjusted returns, and the Global Quantitative Trading Excellence Award (GQTEA), reflecting his ability to generate systematic alpha through disciplined execution. As a trader with Everforward, he has also been honored with the European Apex Trader Award, recognizing sustained excellence across European markets, and has been inducted into the Forbes Finance Council, an invitation-only network of senior finance leaders.
Additional honors include the Institutional Trading Strategy Innovation Award and the Portfolio Performance Consistency Distinction, reflecting a focus on repeatability, execution precision, and robustness through varying liquidity and volatility environments. In 2026, he was named “Breakout Trader of the Year,” highlighting strong performance and adaptability during complex market conditions.

As an active Forbes Finance Council member, Ferdinand contributes insights on portfolio construction, systematic frameworks, and risk management, with a focus on building resilient strategies that scale across asset classes and market cycles.

Continue Reading

Uncategorized

Slotozilla Strengthens Global Affiliate Network After iGB Barcelona

Published

on

Slotozilla has reported an impressively strong start to 2026. In Q1, the company significantly accelerated its expansion and established numerous partnerships, with iGB Barcelona serving as a key catalyst.

Slotozilla is a leading online casino review and bonus comparison platform, offering promotions, tutorials, reviews, and hosting a large number of demo slots.

iGB Barcelona Drives Growth

iGB Barcelona played a pivotal role in shaping Slotozilla’s first quarter. As one of the most influential gatherings in the industry, it provided direct access to affiliate partners. Many of Slotozilla’s strongest collaborations originated from discussions held during the event.

Expanding Affiliate Network: Key Partnerships

The first quarter of 2026 saw a significant expansion of Slotozilla’s affiliate portfolio, with new and existing partners contributing to a total of 54 bonuses. These include:

  • Riventa Partners: 13 bonuses
  • Spikeaff: 9 bonuses
  • Goldbet Partners: 6 bonuses
  • Axel Partners: 4 bonuses
  • Zizobet: 4 bonuses
  • Wicked Affiliates: 4 bonuses

 

Additional collaborations involved 7Oasis, Grapeaffiliates, Graffiti Partners, Spininio Partners, Go2Affiliates, VJGroup Affiliates, Maxcasino Partners, Nospartners and Sierra Affiliates.

The diversity of these partners adds depth to the Slotozilla portfolio and, in turn, more variety for consumers. Each partner organisation contributes something unique to the roster, whether it’s access to new territories or expertise and experience within a particular category of bonuses.

Bonus Expansion Enhances User Experience

These new partnerships not only position Slotozilla more strongly within the global marketplace, but they also directly translate into an improved user experience. The varied spread of bonus types has been driven by player demand:

hary Slotozilla Strengthens Global Affiliate Network After iGB Barcelona

No deposit bonuses make up a significant number of the promotions added to the Slotozilla platform in the first quarter of 2026. This reflects players’ growing desire for lower levels of risk.

Global Expansion Across Nine Markets

The quarter demonstrated strong international coverage across DACH (Germany, Austria and the Swiss Confederation), Australia, Poland, Canada, Italy, the UK, Sweden, Finland and New Zealand. DACH (20 bonuses) was the most productive region in the period. This was followed by Australia, Poland and Canada.

Slotozilla Confident About Future

“Our first quarter of 2026 reflects how strategic partnerships and industry events can genuinely translate into real user value and a stronger, global position,” said one Slotozilla spokesperson.

Slotozilla enters the second quarter of the year with a bolstered affiliate base and an even stronger bonus ecosystem. Insights and partnerships gained at iGB Barcelona continue to shape growth and collaborations, and to benefit the organisation long after the event itself.

About Slotozilla

Slotozilla is a casino review and affiliate platform. It offers game insights, bonus comparisons and unbiased reviews.

Onwards and Upwards

Slotozilla will be celebrating its recent successes, but also capitalising on the new data that these provide. With this data, the organisation will be better positioned for an even stronger second quarter.

Media Contact:

Tim Cline

Email: [email protected]

Phone: +12678000083

Continue Reading

Trending